The FDA approved Pfizer’s new COVID-19 pill, Paxlovid. The pill has been shown to greatly reduce illness and hospitalizations and can be effective for immuno-compromised patients. Europe has already approved the pill — but so far, it’s not clear whether there will be enough supply in the US or abroad. Host Marco Werman speaks to Dr. Eric Topol, director of Scripps Research Translational Institute.